I built a production-grade AI stock-research workflow for US equities — with no prior coding background, in two months, on a single Mac mini. A dual-engine pipeline that reads fundamentals, technicals, and sentiment across 82 tickers, runs 100+ scheduled jobs around the clock, and cross-examines its own analysis before I ever read it.
That is the headline. The background only matters because of the contrast.
Before I was twenty, a hit-and-run collision tore the brachial plexus in my right arm — the bundle of nerves running from the spine into the shoulder. It doesn't heal when it's torn. My right hand lost roughly 95% of its function. Three surgeries. Then I relearned everything with my left hand: shoelaces, writing, typing. I sat the national college entrance exam one-handed. I got in.
Inside the back offices of Wells Fargo, Deutsche Bank, UBS, JPMorgan, and eToro, I did the work with one hand and asked for no lowered standard.
Then ulcerative colitis took my colon. Five more surgeries across eight years — eight operations in total. Today I live with a permanent ostomy for the rest of my life. One body, rebuilt more than once.
In May 2026, I started building. AI became my engineering partner — not a crutch, a collaborator. I described what I wanted; it wrote the first draft; I tested, broke, and hardened it. Two months later: TradingMapClaw. It runs at 4 AM while I sleep, and it does not know or care that it was built by a man with one hand. That is exactly the point.
What I Ask: Not pity. Visibility.
People living with brachial plexus injury, ulcerative colitis, IBD, Crohn's, and permanent ostomies are nearly invisible in the working world — assumed to be fragile, or gone. I didn't disappear. If you're living with any of this: you are not alone. Not anymore.
Research & education only. Not investment advice.